Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04717869 · ClinicalTrials.gov registry record
Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty
A clinical trial of Frailty and Sarcopenia, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT04717869: Recruiting study of Frailty and Sarcopenia, sponsored by University of California, Los Angeles.
NCT04717869 is a study of Frailty and Sarcopenia that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 250 participants, below the 1,501-participant average among 48 other Frailty trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04717869, a study of Frailty and Sarcopenia, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
Frailty, the decline in physical and cognitive reserves leading to vulnerability to stressors is increasingly being recognized as a public health concern. Although multiple measures exist that can identify frail patients, very little is known about how or when to intervene. Sarcopenia, or the degree of muscle wasting, is closely correlated to frailty and patient outcomes. This is a prospective cohort study of critically ill patients to identify modifiable risk factors of sarcopenia, as potential targets to reduce frailty.
Primary Outcome
Disposition of patient at time of hospital discharge, home, rehabilitation or skilled nursing facility, in hospital death
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Ultrasound
- DIAGNOSTIC_TEST Biomarker Analysis
- OTHER Frailty Index
Study Locations (1)
California
- Ronald Reagan UCLA Medical Center, Department of Anesthesiology & Perioperative Medicine - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2023-09-22 |
| Est. Completion | 2026-07 |
What NCT04717869 shows while recruiting
NCT04717869 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 1,501-participant average among 48 other Frailty trials with a reported enrollment target (83% lower).
The record links to 2 conditions, with Frailty appearing as the primary indexed condition, and to 3 interventions - of which Ultrasound is the first listed.
NCT04717869 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04717869 about?
NCT04717869 is a clinical study titled "Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty". Frailty, the decline in physical and cognitive reserves leading to vulnerability to stressors is increasingly being recognized as a public health concern. Although multiple measures exist that can identify frail patients, very little is known about how or when to intervene. Sarcopenia, or the degree...
What is the current status of trial NCT04717869?
This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2023-09-22. Estimated completion is 2026-07.
What conditions does trial NCT04717869 study?
This clinical trial studies the following conditions: Frailty, Sarcopenia.
What interventions are being tested in trial NCT04717869?
The interventions under investigation include: Ultrasound (DIAGNOSTIC_TEST), Biomarker Analysis (DIAGNOSTIC_TEST), Frailty Index (OTHER).
Who is sponsoring clinical trial NCT04717869?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04717869 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Frailty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04717869's enrollment target sits among peer trials
250 7th of 48 higher than 42 of 48 other Frailty trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Frailty trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Physical Ability and Cellular Senescence Elimination in HIV
RECRUITING · Phase 2
-
Reducing Frailty for Older Cancer Survivors Using Supplements II
RECRUITING · Phase 2
-
A Partnered Evaluation to Improve the Identification and Management of Functional Impairment and Frailty Among Older Veterans in Primary Care Settings
RECRUITING · NA
-
Occupational Therapy and Registered Dietitian Services to Reduce Fall Risk Among Home Delivered Meal Clients
RECRUITING · NA
-
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
RECRUITING · Phase 2
-
Evaluation of the Walk With Ease Program for Fall Prevention
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI